Efficacy and safety of vornorexant in Japanese patients with insomnia: a randomized, placebo-controlled phase 3 pivotal study.

Uchiyama M, Kambe D, Hasegawa S, Imadera Y, Yamasaki H, Uchimura N

Open source

DOI
10.1093/sleep/zsaf291
Published
2026 Mar 11
Container
Sleep
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/sleep/zsaf291,
  title = {Efficacy and safety of vornorexant in Japanese patients with insomnia: a randomized, placebo-controlled phase 3 pivotal study.},
  author = {Uchiyama M and Kambe D and Hasegawa S and Imadera Y and Yamasaki H and Uchimura N},
  year = {2026},
  journal = {Sleep},
  doi = {10.1093/sleep/zsaf291},
  url = {https://doi.org/10.1093/sleep/zsaf291}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of vornorexant in Japanese patients with insomnia: a randomized, placebo-controlled phase 3 pivotal study.
AU  - Uchiyama M
AU  - Kambe D
AU  - Hasegawa S
AU  - Imadera Y
AU  - Yamasaki H
AU  - Uchimura N
PY  - 2026
JO  - Sleep
DO  - 10.1093/sleep/zsaf291
UR  - https://doi.org/10.1093/sleep/zsaf291
ER  - 

APA

M, U., D, K., S, H., Y, I., H, Y., & N, U. (2026). Efficacy and safety of vornorexant in Japanese patients with insomnia: a randomized, placebo-controlled phase 3 pivotal study.. Sleep. https://doi.org/10.1093/sleep/zsaf291

Source records